menu
    • menu

    Company profile for Attralus

    NEW Drugs in Dev: 6
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Attralus is a biopharmaceutical company focused on illuminating the systemic nature of amyloidosis and creating transformative medicines to improve the lives of patients. The company’s proprietary peptide-based pan-amyloid targeting agents have the potential to diagnose and treat all forms and stages of systemic amyloidosis. Attralus is focused on targeting common pathology in all systemic amyloidosis diseases, with the goal...
    Attralus is a biopharmaceutical company focused on illuminating the systemic nature of amyloidosis and creating transformative medicines to improve the lives of patients. The company’s proprietary peptide-based pan-amyloid targeting agents have the potential to diagnose and treat all forms and stages of systemic amyloidosis. Attralus is focused on targeting common pathology in all systemic amyloidosis diseases, with the goal of developing treatments for all subtypes of amyloidosis, including the majority in which there are currently no treatment options.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AttralusUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    ‍329 Oyster Point Blvd Third Floor South San Francisco, CA 94080
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://attralus.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/attralus

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Natural Product Expo West

    Natural Product Expo West

    Not Confirmed

    envelop Contact Supplier

    Natural Product Expo West

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Bayer Acquires Attralus Radiotracers, Molecular Imaging
    Bayer Acquires Attralus Radiotracers, Molecular Imaging

    13 Jan 2026

    // CONTRACTPHARMA

    https://www.contractpharma.com/breaking-news/bayer-acquires-attralus-radiotracers-expands-into-molecular-imaging/

    CONTRACTPHARMA
    13 Jan 2026
    Share Share
    Bayer Acquires Pan-Amyloid Radiotracers For Molecular Imaging
    Bayer Acquires Pan-Amyloid Radiotracers For Molecular Imaging

    12 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260112759592/en/Bayer-to-Expand-Into-Molecular-Imaging-With-Acquisition-of-Innovative-Pan-Amyloid-Radiotracers-From-Attralus

    BUSINESSWIRE
    12 Jan 2026
    Share Share
    Attralus Unveils Pan-Amyloid Diagnostic Imaging Data at ASNC 2025
    Attralus Unveils Pan-Amyloid Diagnostic Imaging Data at ASNC 2025

    08 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/08/3145979/0/en/Attralus-Presents-New-Data-on-Its-Pan-Amyloid-Diagnostic-Imaging-Candidates-at-ASNC-2025.html

    GLOBENEWSWIRE
    08 Sep 2025
    Share Share
    Attralus Presents Data on Pan-Amyloid Diagnostics at ACC Session
    Attralus Presents Data on Pan-Amyloid Diagnostics at ACC Session

    01 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/01/3053148/0/en/Attralus-Presents-New-Data-on-Its-Pan-Amyloid-Diagnostic-Candidates-at-the-2025-American-College-of-Cardiology-ACC-Annual-Scientific-Session.html

    GLOBENEWSWIRE
    01 Apr 2025
    Share Share
    Attralus Begins Crucial Phase In Cardiac Treatment Research
    Attralus Begins Crucial Phase In Cardiac Treatment Research

    15 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/15/3009885/0/en/Attralus-Announces-Enrollment-of-First-Patient-in-Phase-3-Trial-for-the-Pan-Amyloid-Diagnostic-124I-evuzamitide-AT-01-for-Cardiac-Amyloidosis.html

    GLOBENEWSWIRE
    15 Jan 2025
    Share Share
    Attralus AT-02 Get FDA Orphan Drug Designation for ATTR Amyloidosis
    Attralus AT-02 Get FDA Orphan Drug Designation for ATTR Amyloidosis

    12 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/12/2978891/0/en/Attralus-Therapeutic-AT-02-Receives-Orphan-Drug-Designation-from-the-U-S-FDA-for-the-Treatment-of-ATTR-Amyloidosis.html

    GLOBENEWSWIRE
    12 Nov 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search